Back to Search
Start Over
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide.
- Source :
- Clinical Case Reports; May2021, Vol. 9 Issue 5, p1-5, 5p
- Publication Year :
- 2021
-
Abstract
- Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR. [ABSTRACT FROM AUTHOR]
- Subjects :
- HYPOGLYCEMIA
INSULINOMA
SOMATOSTATIN
Subjects
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 9
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- 150698705
- Full Text :
- https://doi.org/10.1002/ccr3.4118